Back to search

Article

SARS-CoV-2 Mpro protease as a biomarker and therapeutic target in Long COVID: a real-world prospective cohort study

2026-02-19

Abstract excerpt

<title>Abstract</title> <p> Long COVID affects 400 million people worldwide, for whom predictive biomarkers and effective therapies are urgently needed. Herein, we investigate SARS-CoV-2 viral RNAs as candidate biomarkers and therapeutic targets. Combining whole blood digital transcriptomics and plasma proteomics, viral RNAs significantly correlated with platelet-expressed genes/proteins and complement/coagulati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ac82d76f-c97f-53b6-9f04-95e3f89e05a5
DOI
10.21203/rs.3.rs-7449833/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Mpro protease as a biomarker and therapeutic target in Long COVID: a real-world prospective cohort studyDOI 10.21203/rs.3.rs-7449833/v1
Select a neighboring publication to make it the new centre.